You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-obesity Medication

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SELECT-LIFE: A Research Study Looking at Long-term Effects of

Enrolling by invitation
  • Overweight
  • Obesity
  • No treatment given
  • Plainsboro, New Jersey
  • +9 more
Mar 30, 2022

Obesity, Obesity; Drug, Lifestyle, Healthy Trial in United States (Online Lifestyle Behavioral Therapy, Phentermine

Recruiting
  • Obesity
  • +2 more
  • Online Lifestyle Behavioral Therapy
  • Phentermine Hydrochloride 8 MG
  • Los Angeles, California
  • +4 more
Jun 30, 2022

Hypertension, Medication Adherence Trial in Zhengzhou (behavior management for anti-hypertensive medication, group)

Completed
  • Hypertension
  • Medication Adherence
  • behavior management for anti-hypertensive medication
  • placebo group
  • Zhengzhou, Henan, China
    Senior Residences of Henan Province
Jul 10, 2023

Anti-obesity Pharmacotherapy and Inflammation

Not yet recruiting
  • Obesity
  • Liraglutide or Semaglutide
  • Phentermine-Topiramate combination
  • New Orleans, Louisiana
  • +1 more
Mar 3, 2023

Epilepsy, Pregnancy Related Trial in Pittsburgh (Lamotrigine, Levetiracetam)

Recruiting
  • Epilepsy
  • Pregnancy Related
  • Pittsburgh, Pennsylvania
    Kaufmann Medical Building
Jan 4, 2023

Obesity Trial in Cleveland (Weight Management Program (WMP), Medication for chronic weight management (Rx))

Completed
Has Results
  • Obesity
  • Weight Management Program (WMP)
  • Medication for chronic weight management (Rx)
  • Cleveland, Ohio
    Novo Nordisk Investigational Site
Nov 10, 2022

Obesity, Morbid, Bariatric Surgery Candidate, Medication Persistence Trial (Naltrexone-Bupropion Combination)

Not yet recruiting
  • Obesity, Morbid
  • +2 more
  • Naltrexone-Bupropion Combination
  • (no location specified)
Jul 26, 2022

Binge-Eating Disorder, Obesity Trial in New Haven (Naltrexone and Bupropion, Placebo)

Recruiting
  • Binge-Eating Disorder
  • Obesity
  • Naltrexone and Bupropion
  • Placebo
  • New Haven, Connecticut
    Yale Department of Psychiatry
Dec 21, 2022

Obesity Trial in Philadelphia (Behavioral Treatment, Placebo, Phentermine 15 MG)

Completed
  • Obesity
  • Behavioral Treatment
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Center for Weight and Eating Disorder
Sep 13, 2022

Patent Foramen Ovale, Migraine Trial (Aspirin 100mg, Metoprolol 25 Mg Oral Tablet, Clopidogrel 75mg)

Recruiting
  • Patent Foramen Ovale
  • Migraine
  • Aspirin 100mg
  • +3 more
  • Beijing, Beijing, China
    Fuwai Hospital
Jan 9, 2023

Type1 Diabetes, Obesity Trial in Milan (Microbiome-targeted diet, Usual care diet)

Recruiting
  • Type1 Diabetes
  • Obesity
  • Microbiome-targeted diet
  • Usual care diet
  • Milan, Milano, Italy
  • +1 more
Mar 1, 2023

Post-fracture Medication and Mortality

Completed
  • Osteoporosis
  • +4 more
  • Anti-osteoporosis medications
  • Tainan, Taiwan
    Department of Family Medicine, National Cheng Kung Univ Hosp
May 9, 2022

Obesity, Adult Trial in Riyadh (Probiotic, Placebo)

Active, not recruiting
  • Obesity
  • Adult
  • Riyadh, Saudi Arabia
    King Saud University
Dec 24, 2022

Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)

Recruiting
  • Obesity
  • Loma Linda, California
    Novo Nordisk Investigational Site
Jan 24, 2023

Hypertension, HIV-1-infection Trial in Durham (Hypertension control through education and monitoring)

Recruiting
  • Hypertension
  • HIV-1-infection
  • Hypertension control through education and monitoring
  • Durham, North Carolina
    Duke University
Aug 4, 2022

Stroke, Medication Adherence Trial in Kumasi (Polycap)

Not yet recruiting
  • Stroke
  • Medication Adherence
  • Kumasi, Ghana
    Kwame Nkrumah Institute of Science & Technology
Jul 19, 2023

Obesity, Childhood Trial in Minneapolis (Intensive Behavioral Program, Semaglutide and Behavioral Program)

Recruiting
  • Obesity, Childhood
  • Intensive Behavioral Program
  • Semaglutide and Behavioral Program
  • Minneapolis, Minnesota
    University of Minnesota, Delaware Clinical Research Unit
Mar 17, 2022

Body Composition Improvement With Visceral Adiposity-Focused

Recruiting
  • Obesity
  • +3 more
  • 20Lighter Program
  • Little Rock, Arkansas
  • +1 more
Dec 18, 2022

Idiopathic Intracranial Hypertension, Intracranial Pressure, Obesity Trial in Glostrup, Odense (drug, dietary supplement,

Recruiting
  • Idiopathic Intracranial Hypertension
  • +5 more
  • Glostrup, Denmark
  • +1 more
Sep 7, 2023

Fragility Fracture Liaison Service and Anti-osteoporosis

Recruiting
  • Osteoporosis
  • Fracture
    • Hsinchu, Taiwan
      National Taiwan University Hospital, Chutung branch
    May 3, 2022

    Atrial Fibrillation, Obesity, Prognosis Trial in Suwon (Oral anticoagulant)

    Active, not recruiting
    • Atrial Fibrillation
    • +3 more
    • Oral anticoagulant
    • Suwon, Gyeong-gido, Korea, Republic of
      Ajou University School of Medicine
    Dec 11, 2022

    Adjunctive Anti-seizure Medication Real World Evidence Study

    Recruiting
    • Epilepsy
    • ASM as adjunctive therapy
    • Milan, Italy
      Fondazione IRCCS Istituto Neurologico "Carlo Besta" U.O. Epilett
    May 17, 2023

    Overweight and Obesity, Hypercholesterolemia, Hypertriglyceridemia Trial in Murcia (Silibinin A)

    Active, not recruiting
    • Overweight and Obesity
    • +2 more
    • Silibinin A
    • Murcia, Spain
      Faculty of Nursing. Catholic University of Murcia
    May 17, 2022

    Overweight and Obesity Trial in Lahore (Phaseolus Vulgaris, Placebo)

    Not yet recruiting
    • Overweight and Obesity
    • Phaseolus Vulgaris
    • Placebo
    • Lahore, Punjab, Pakistan
    • +1 more
    Jul 6, 2022

    Loss-of-control Eating, Obesity/Overweight Trial in New Haven (Lisdexamfetamine Dimesylate (Medication), Placebo)

    Enrolling by invitation
    • Loss-of-control Eating
    • Obesity/Overweight
    • Lisdexamfetamine Dimesylate (Medication)
    • Placebo
    • New Haven, Connecticut
      Yale School of Medicine
    Oct 4, 2022